Pediatric Clinical Trials Market Forecasted Growth with New Innovations and Global Reach in 2023
December 20, 2023 10:08 ET
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Clinical Trials Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The pediatric clinical trials...
Global KRAS Inhibitors Market Research Report 2023: A $4 Billion Opportunity by 2029, 200% Growth in 2022, 60 Drugs in Clinical Trials, 2 Approved Drugs
June 07, 2023 10:18 ET
|
Research and Markets
Dublin, June 07, 2023 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market, Drug Price, Sales, & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. ...
Global Clinical Trials Market Report 2023: Globalized Drug Development Activities Bolsters Growth
April 12, 2023 08:08 ET
|
Research and Markets
Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Market (2023-2028) by Study Phases, Study Designs, Indication of Disease and Geography, Impact of Covid-19 with Ansoff...
Outlook on the KRAS Inhibitors Global Market, Drug Price, Sales, & Clinical Trials Insight to 2029
February 08, 2023 07:38 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market, Drug Price, Sales, & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...
Outlook on the KRAS Inhibitors Global Market to 2028 - Key Drivers and Challenges
April 27, 2022 05:28 ET
|
Research and Markets
Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.com's offering. The advancement in...
Indian Clinical Trials Market Outlook to 2030 - Featuring Key Players Iqvia Holdings, Icon plc, PRA Health Sciences, Inc. and Syngene International Among Others
March 11, 2022 07:13 ET
|
Research and Markets
Dublin, March 11, 2022 (GLOBE NEWSWIRE) -- The "Indian Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design...
CELSION ANNOUNCES PUBLICATION OF THERMODOX® PHASE I CLINICAL STUDY RESULTS IN THE LANCET ONCOLOGY
July 10, 2018 08:00 ET
|
Celsion CORP
– The TARDOX Study, in Collaboration with University of Oxford, Evaluates the Use of Focused Ultrasound in Combination with ThermoDox® to Treat Primary and Metastatic Liver Cancer – – Imaging...
Novogen Cardiovascular Drug Enters Phase I Clinical Trial
April 02, 2008 08:00 ET
|
Novogen, Limited
SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - April 2, 2008) - Novogen today
announced the commencement of a Phase I human clinical trial of the novel
cardiovascular drug, NV-27. This drug is...